Oncology – Bone and Sarcomas
RCT: Efficacy and safety of TRC105 plus pazopanib vs. pazopanib alone for treatment of patients with advanced angiosarcoma.
27 May, 2022 | 11:15h | UTCCommentaries:
Addition of Carotuximab to Pazopanib in Advanced Angiosarcoma – The ASCO Post
Commentaries on Twitter
A phase III trial in 123 patients with advanced-stage angiosarcoma reveals no significant difference in mPFS with pazopanib plus the anti-endoglin (CD105) mAb carotuximab vs pazopanib alone: https://t.co/TPPFRNCOoC #scmsm #caxtx
— NatureRevClinOncol (@NatRevClinOncol) April 5, 2022
First randomized trial in angiosarcoma demonstrates no signif difference in progression-free survival for combo of novel angiogenesis inhibitor carotuximab + pazopanib vs. pazopanib alone in advanced angiosarcoma. https://t.co/f1Z5EjOdK2 pic.twitter.com/qf3Tez9VU2
— JAMA Oncology (@JAMAOnc) March 31, 2022
RCT: Selinexor in advanced, metastatic dedifferentiated liposarcoma.
12 Apr, 2022 | 08:24h | UTC
Guidelines for diagnosing incidental solitary bone lesions on CT and MRI in adults: bone reporting and data system (Bone-RADS).
4 Apr, 2022 | 00:45h | UTC
Commentary on Twitter (article and images under a http://creativecommons.org/licenses/by-nc/4.0/)
Bone RADS- White Paper from @SkeletalRadiol
Want to know how to handle bone lesions? Take a look – open access:https://t.co/mBUFzgJiCf@cychang1414 @ahlawat_shivani @HillaryGarnerMD@mbucknor @Radsdoc82 @behrangamini @IKhodarahmi @JimWuMSK
Apologies couldn't find all authors pic.twitter.com/hL8r04uK40— Adam Singer, MD (@AdamSingerMD) April 1, 2022
Educational Review: Multiparametric MRI evaluation of bone sarcomas in children.
3 Mar, 2022 | 07:54h | UTCMultiparametric MRI evaluation of bone sarcomas in children – Insights into Imaging
RCT: Prolonging prophylactic intravenous antibiotic regimens not beneficial after endoprosthetic reconstruction for lower extremity bone tumors.
19 Jan, 2022 | 08:37h | UTCCommentary: No Benefit Seen With Longer Antibiotic Course After Surgery for Bone Tumors – Cancer Therapy Advisor
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERNPaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.
1 Oct, 2021 | 09:57h | UTC
ASTRO Guideline: Radiation therapy for treatment of soft tissue sarcoma in adults.
29 Jul, 2021 | 10:54h | UTCNews release: Astro Issues Clinical Guideline on Radiation Therapy for Soft Tissue Sarcoma in Adults
ESMO Guidelines: Soft tissue and visceral sarcomas.
29 Jul, 2021 | 10:53h | UTC
Meta-analysis: Bisphosphonates or RANK‐ligand‐inhibitors for men with prostate cancer and bone metastases
20 Jan, 2021 | 01:09h | UTC